JAKARTA, iNews.id – Ovarian cancer often go undetected for most women. Without realizing, cancer it has spread in the pelvis and abdomen. If it is in the late stages, ovarian cancer will be difficult to treat.
The lack of information and public knowledge about ovarian cancer, compared to breast cancer or cervical cancer, which includes cancer in women, is one of the obstacles to prevention and early detection efforts.
In fact, ovarian cancer is the 8th leading cause of cancer death in women worldwide. In Indonesia, ovarian cancer is ranked 3rd in terms of incidence and mortality rates for cancer in women.
The six risk factors for ovarian cancer are having a history of endometrial cysts, having a family history of ovarian cancer and breast cancer, having genetic mutations (eg BRCA), low parity, poor lifestyle and increasing age.
Four signs of ovarian cancer are bloating, decreased appetite, frequent urination, and pelvic or abdominal pain. In general, ovarian cancer is not accompanied by symptoms in its early stages.
Chairman of the Indonesian Oncology and Gynecology Association (HOGI), Prof. DR. dr. Andrijono, Sp.OG(K) said every woman needs to be aware of the threat of ovarian cancer by recognizing risk factors and early detection of ovarian cancer. Cancer Symptoms Ovaries are often mistaken for symptoms of other diseases, so they often go unnoticed and only discovered when they have reached an advanced stage.
“In fact, if detected early, ovarian cancer can be treated. But the fact is that 20 percent of ovarian cancers are detected at an early stage, 94 percent of these early-stage patients will be able to live more than 5 years after being diagnosed,” said Prof Andrijono, through his virtual statement.
Furthermore, Prof. Andrijono said, the PAP Smear test could not detect ovarian cancer and there were no specific symptoms as an early marker. Therefore, the 10 Fingers Campaign will help Indonesian women to be more aware of ovarian cancer.
Immediately see a doctor, if you have one of the six risk factors and one of the four symptoms of ovarian cancer.
He explained, HOGI appreciates the synergy with AstraZeneca and CISC in an effort to increase the awareness of Indonesian women about ovarian cancer. It is hoped that more women will have early detection of ovarian cancer and have a better life expectancy.
Editor : Vien Dimyati
